| United Summit Center Inc | |
|
6 Hospital Plz Clarksburg WV 26301-9316 | |
| (304) 623-5661 | |
| (304) 623-2989 |
| Full Name | United Summit Center Inc |
|---|---|
| Speciality | Counselor |
| Location | 6 Hospital Plz, Clarksburg, West Virginia |
| Authorized Official Name and Position | Lisa Price (AUTHORIZED OFFICIAL) |
| Authorized Official Contact | 3046235661 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| United Summit Center Inc 6 Hospital Plz Clarksburg WV 26301-9316 Ph: (304) 598-6280 | United Summit Center Inc 6 Hospital Plz Clarksburg WV 26301-9316 Ph: (304) 623-5661 |
| NPI Number | 1750332524 |
|---|---|
| Provider Enumeration Date | 05/15/2006 |
| Last Update Date | 06/23/2021 |
| Certification Date | 06/23/2021 |
| Medicare PECOS PAC ID | 6002803988 |
|---|---|
| Medicare Enrollment ID | O20040430000886 |
News Archive
The death of a 44-year-old man four days ago from bird flu has put Indonesia on a par with Vietnam when it comes to confirmed human deaths from the deadly virus.
Many clinical trials for breast cancer fail to give clear answers on the efficacy of new therapies, despite enrolling thousands of patients and painstakingly tracking their outcomes for years.
Researchers at The University of Texas Health Science Center at Houston (UTHealth) are launching a new research study to find the best way to give blood transfusions for severely injured patients predicted to require massive blood transfusions upon arrival to the Memorial Hermann-Texas Medical Center emergency department. Bryan Cotton, M.D., of UTHealth is principal investigator for this clinical study.
Ventas, Inc. and Nationwide Health Properties, Inc. today announced that the Boards of Directors of both companies have unanimously approved a definitive agreement under which Ventas will acquire all of the outstanding shares of NHP in a stock-for-stock transaction valued at $7.4 billion, creating one of the largest publicly traded REITs and the leading healthcare REIT by equity value.
Amgen Inc. today announced results from three studies on the safety and efficacy of Nplate® (romiplostim) in adult patients with myelodysplastic syndromes (MDS).
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750332524 | NPI | - | NPPES |
| 0005239000 | Medicaid | WV | |
| 0005239002 | Medicaid | WV | |
| 0017100654 | Other | WV | BLUE CROSS BLUE SHIELD |
| 001710655 | Other | WV | BLUE CROSS BLUE SHIELD |
| 0018101987 | Other | WV | BLUE CROSS BLUE SHIELD |
| 0005239001 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 20 (West Virginia) | Primary |
| Provider Name | Mary Ann Long |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1679685150 PECOS PAC ID: 6709864309 Enrollment ID: I20040709001360 |
News Archive
The death of a 44-year-old man four days ago from bird flu has put Indonesia on a par with Vietnam when it comes to confirmed human deaths from the deadly virus.
Many clinical trials for breast cancer fail to give clear answers on the efficacy of new therapies, despite enrolling thousands of patients and painstakingly tracking their outcomes for years.
Researchers at The University of Texas Health Science Center at Houston (UTHealth) are launching a new research study to find the best way to give blood transfusions for severely injured patients predicted to require massive blood transfusions upon arrival to the Memorial Hermann-Texas Medical Center emergency department. Bryan Cotton, M.D., of UTHealth is principal investigator for this clinical study.
Ventas, Inc. and Nationwide Health Properties, Inc. today announced that the Boards of Directors of both companies have unanimously approved a definitive agreement under which Ventas will acquire all of the outstanding shares of NHP in a stock-for-stock transaction valued at $7.4 billion, creating one of the largest publicly traded REITs and the leading healthcare REIT by equity value.
Amgen Inc. today announced results from three studies on the safety and efficacy of Nplate® (romiplostim) in adult patients with myelodysplastic syndromes (MDS).
› Verified 2 days ago
| Provider Name | Franklin B Curry |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1922110816 PECOS PAC ID: 4486793718 Enrollment ID: I20091130000369 |
News Archive
The death of a 44-year-old man four days ago from bird flu has put Indonesia on a par with Vietnam when it comes to confirmed human deaths from the deadly virus.
Many clinical trials for breast cancer fail to give clear answers on the efficacy of new therapies, despite enrolling thousands of patients and painstakingly tracking their outcomes for years.
Researchers at The University of Texas Health Science Center at Houston (UTHealth) are launching a new research study to find the best way to give blood transfusions for severely injured patients predicted to require massive blood transfusions upon arrival to the Memorial Hermann-Texas Medical Center emergency department. Bryan Cotton, M.D., of UTHealth is principal investigator for this clinical study.
Ventas, Inc. and Nationwide Health Properties, Inc. today announced that the Boards of Directors of both companies have unanimously approved a definitive agreement under which Ventas will acquire all of the outstanding shares of NHP in a stock-for-stock transaction valued at $7.4 billion, creating one of the largest publicly traded REITs and the leading healthcare REIT by equity value.
Amgen Inc. today announced results from three studies on the safety and efficacy of Nplate® (romiplostim) in adult patients with myelodysplastic syndromes (MDS).
› Verified 2 days ago
| Provider Name | James Abel |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1376729244 PECOS PAC ID: 7214120369 Enrollment ID: I20101021000054 |
News Archive
The death of a 44-year-old man four days ago from bird flu has put Indonesia on a par with Vietnam when it comes to confirmed human deaths from the deadly virus.
Many clinical trials for breast cancer fail to give clear answers on the efficacy of new therapies, despite enrolling thousands of patients and painstakingly tracking their outcomes for years.
Researchers at The University of Texas Health Science Center at Houston (UTHealth) are launching a new research study to find the best way to give blood transfusions for severely injured patients predicted to require massive blood transfusions upon arrival to the Memorial Hermann-Texas Medical Center emergency department. Bryan Cotton, M.D., of UTHealth is principal investigator for this clinical study.
Ventas, Inc. and Nationwide Health Properties, Inc. today announced that the Boards of Directors of both companies have unanimously approved a definitive agreement under which Ventas will acquire all of the outstanding shares of NHP in a stock-for-stock transaction valued at $7.4 billion, creating one of the largest publicly traded REITs and the leading healthcare REIT by equity value.
Amgen Inc. today announced results from three studies on the safety and efficacy of Nplate® (romiplostim) in adult patients with myelodysplastic syndromes (MDS).
› Verified 2 days ago
| Provider Name | Michelle L Ryan |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1952659575 PECOS PAC ID: 6103070560 Enrollment ID: I20130212000218 |
News Archive
The death of a 44-year-old man four days ago from bird flu has put Indonesia on a par with Vietnam when it comes to confirmed human deaths from the deadly virus.
Many clinical trials for breast cancer fail to give clear answers on the efficacy of new therapies, despite enrolling thousands of patients and painstakingly tracking their outcomes for years.
Researchers at The University of Texas Health Science Center at Houston (UTHealth) are launching a new research study to find the best way to give blood transfusions for severely injured patients predicted to require massive blood transfusions upon arrival to the Memorial Hermann-Texas Medical Center emergency department. Bryan Cotton, M.D., of UTHealth is principal investigator for this clinical study.
Ventas, Inc. and Nationwide Health Properties, Inc. today announced that the Boards of Directors of both companies have unanimously approved a definitive agreement under which Ventas will acquire all of the outstanding shares of NHP in a stock-for-stock transaction valued at $7.4 billion, creating one of the largest publicly traded REITs and the leading healthcare REIT by equity value.
Amgen Inc. today announced results from three studies on the safety and efficacy of Nplate® (romiplostim) in adult patients with myelodysplastic syndromes (MDS).
› Verified 2 days ago
| Provider Name | Ja'me A Brandish |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1285070714 PECOS PAC ID: 6709026487 Enrollment ID: I20130628000646 |
News Archive
The death of a 44-year-old man four days ago from bird flu has put Indonesia on a par with Vietnam when it comes to confirmed human deaths from the deadly virus.
Many clinical trials for breast cancer fail to give clear answers on the efficacy of new therapies, despite enrolling thousands of patients and painstakingly tracking their outcomes for years.
Researchers at The University of Texas Health Science Center at Houston (UTHealth) are launching a new research study to find the best way to give blood transfusions for severely injured patients predicted to require massive blood transfusions upon arrival to the Memorial Hermann-Texas Medical Center emergency department. Bryan Cotton, M.D., of UTHealth is principal investigator for this clinical study.
Ventas, Inc. and Nationwide Health Properties, Inc. today announced that the Boards of Directors of both companies have unanimously approved a definitive agreement under which Ventas will acquire all of the outstanding shares of NHP in a stock-for-stock transaction valued at $7.4 billion, creating one of the largest publicly traded REITs and the leading healthcare REIT by equity value.
Amgen Inc. today announced results from three studies on the safety and efficacy of Nplate® (romiplostim) in adult patients with myelodysplastic syndromes (MDS).
› Verified 2 days ago
| Provider Name | Paris Cleopatra Turner |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1891108981 PECOS PAC ID: 6103124334 Enrollment ID: I20160420002447 |
News Archive
The death of a 44-year-old man four days ago from bird flu has put Indonesia on a par with Vietnam when it comes to confirmed human deaths from the deadly virus.
Many clinical trials for breast cancer fail to give clear answers on the efficacy of new therapies, despite enrolling thousands of patients and painstakingly tracking their outcomes for years.
Researchers at The University of Texas Health Science Center at Houston (UTHealth) are launching a new research study to find the best way to give blood transfusions for severely injured patients predicted to require massive blood transfusions upon arrival to the Memorial Hermann-Texas Medical Center emergency department. Bryan Cotton, M.D., of UTHealth is principal investigator for this clinical study.
Ventas, Inc. and Nationwide Health Properties, Inc. today announced that the Boards of Directors of both companies have unanimously approved a definitive agreement under which Ventas will acquire all of the outstanding shares of NHP in a stock-for-stock transaction valued at $7.4 billion, creating one of the largest publicly traded REITs and the leading healthcare REIT by equity value.
Amgen Inc. today announced results from three studies on the safety and efficacy of Nplate® (romiplostim) in adult patients with myelodysplastic syndromes (MDS).
› Verified 2 days ago
| Provider Name | Stacey J Ball |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1982148813 PECOS PAC ID: 4385813872 Enrollment ID: I20170117001206 |
News Archive
The death of a 44-year-old man four days ago from bird flu has put Indonesia on a par with Vietnam when it comes to confirmed human deaths from the deadly virus.
Many clinical trials for breast cancer fail to give clear answers on the efficacy of new therapies, despite enrolling thousands of patients and painstakingly tracking their outcomes for years.
Researchers at The University of Texas Health Science Center at Houston (UTHealth) are launching a new research study to find the best way to give blood transfusions for severely injured patients predicted to require massive blood transfusions upon arrival to the Memorial Hermann-Texas Medical Center emergency department. Bryan Cotton, M.D., of UTHealth is principal investigator for this clinical study.
Ventas, Inc. and Nationwide Health Properties, Inc. today announced that the Boards of Directors of both companies have unanimously approved a definitive agreement under which Ventas will acquire all of the outstanding shares of NHP in a stock-for-stock transaction valued at $7.4 billion, creating one of the largest publicly traded REITs and the leading healthcare REIT by equity value.
Amgen Inc. today announced results from three studies on the safety and efficacy of Nplate® (romiplostim) in adult patients with myelodysplastic syndromes (MDS).
› Verified 2 days ago
| Provider Name | Pamela J Fisher |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1447706882 PECOS PAC ID: 0648556480 Enrollment ID: I20170411001050 |
News Archive
The death of a 44-year-old man four days ago from bird flu has put Indonesia on a par with Vietnam when it comes to confirmed human deaths from the deadly virus.
Many clinical trials for breast cancer fail to give clear answers on the efficacy of new therapies, despite enrolling thousands of patients and painstakingly tracking their outcomes for years.
Researchers at The University of Texas Health Science Center at Houston (UTHealth) are launching a new research study to find the best way to give blood transfusions for severely injured patients predicted to require massive blood transfusions upon arrival to the Memorial Hermann-Texas Medical Center emergency department. Bryan Cotton, M.D., of UTHealth is principal investigator for this clinical study.
Ventas, Inc. and Nationwide Health Properties, Inc. today announced that the Boards of Directors of both companies have unanimously approved a definitive agreement under which Ventas will acquire all of the outstanding shares of NHP in a stock-for-stock transaction valued at $7.4 billion, creating one of the largest publicly traded REITs and the leading healthcare REIT by equity value.
Amgen Inc. today announced results from three studies on the safety and efficacy of Nplate® (romiplostim) in adult patients with myelodysplastic syndromes (MDS).
› Verified 2 days ago
| Provider Name | Mary Sue Taylor |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1780233247 PECOS PAC ID: 5698006872 Enrollment ID: I20191021000551 |
News Archive
The death of a 44-year-old man four days ago from bird flu has put Indonesia on a par with Vietnam when it comes to confirmed human deaths from the deadly virus.
Many clinical trials for breast cancer fail to give clear answers on the efficacy of new therapies, despite enrolling thousands of patients and painstakingly tracking their outcomes for years.
Researchers at The University of Texas Health Science Center at Houston (UTHealth) are launching a new research study to find the best way to give blood transfusions for severely injured patients predicted to require massive blood transfusions upon arrival to the Memorial Hermann-Texas Medical Center emergency department. Bryan Cotton, M.D., of UTHealth is principal investigator for this clinical study.
Ventas, Inc. and Nationwide Health Properties, Inc. today announced that the Boards of Directors of both companies have unanimously approved a definitive agreement under which Ventas will acquire all of the outstanding shares of NHP in a stock-for-stock transaction valued at $7.4 billion, creating one of the largest publicly traded REITs and the leading healthcare REIT by equity value.
Amgen Inc. today announced results from three studies on the safety and efficacy of Nplate® (romiplostim) in adult patients with myelodysplastic syndromes (MDS).
› Verified 2 days ago
| Provider Name | Auvid Momen |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1164712253 PECOS PAC ID: 8820211006 Enrollment ID: I20200114000009 |
News Archive
The death of a 44-year-old man four days ago from bird flu has put Indonesia on a par with Vietnam when it comes to confirmed human deaths from the deadly virus.
Many clinical trials for breast cancer fail to give clear answers on the efficacy of new therapies, despite enrolling thousands of patients and painstakingly tracking their outcomes for years.
Researchers at The University of Texas Health Science Center at Houston (UTHealth) are launching a new research study to find the best way to give blood transfusions for severely injured patients predicted to require massive blood transfusions upon arrival to the Memorial Hermann-Texas Medical Center emergency department. Bryan Cotton, M.D., of UTHealth is principal investigator for this clinical study.
Ventas, Inc. and Nationwide Health Properties, Inc. today announced that the Boards of Directors of both companies have unanimously approved a definitive agreement under which Ventas will acquire all of the outstanding shares of NHP in a stock-for-stock transaction valued at $7.4 billion, creating one of the largest publicly traded REITs and the leading healthcare REIT by equity value.
Amgen Inc. today announced results from three studies on the safety and efficacy of Nplate® (romiplostim) in adult patients with myelodysplastic syndromes (MDS).
› Verified 2 days ago
| Provider Name | Lauren Mayle |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1205330909 PECOS PAC ID: 2769726041 Enrollment ID: I20220811000109 |
News Archive
The death of a 44-year-old man four days ago from bird flu has put Indonesia on a par with Vietnam when it comes to confirmed human deaths from the deadly virus.
Many clinical trials for breast cancer fail to give clear answers on the efficacy of new therapies, despite enrolling thousands of patients and painstakingly tracking their outcomes for years.
Researchers at The University of Texas Health Science Center at Houston (UTHealth) are launching a new research study to find the best way to give blood transfusions for severely injured patients predicted to require massive blood transfusions upon arrival to the Memorial Hermann-Texas Medical Center emergency department. Bryan Cotton, M.D., of UTHealth is principal investigator for this clinical study.
Ventas, Inc. and Nationwide Health Properties, Inc. today announced that the Boards of Directors of both companies have unanimously approved a definitive agreement under which Ventas will acquire all of the outstanding shares of NHP in a stock-for-stock transaction valued at $7.4 billion, creating one of the largest publicly traded REITs and the leading healthcare REIT by equity value.
Amgen Inc. today announced results from three studies on the safety and efficacy of Nplate® (romiplostim) in adult patients with myelodysplastic syndromes (MDS).
› Verified 2 days ago
| Provider Name | Amber Davis |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1467164475 PECOS PAC ID: 1557722832 Enrollment ID: I20230802003793 |
News Archive
The death of a 44-year-old man four days ago from bird flu has put Indonesia on a par with Vietnam when it comes to confirmed human deaths from the deadly virus.
Many clinical trials for breast cancer fail to give clear answers on the efficacy of new therapies, despite enrolling thousands of patients and painstakingly tracking their outcomes for years.
Researchers at The University of Texas Health Science Center at Houston (UTHealth) are launching a new research study to find the best way to give blood transfusions for severely injured patients predicted to require massive blood transfusions upon arrival to the Memorial Hermann-Texas Medical Center emergency department. Bryan Cotton, M.D., of UTHealth is principal investigator for this clinical study.
Ventas, Inc. and Nationwide Health Properties, Inc. today announced that the Boards of Directors of both companies have unanimously approved a definitive agreement under which Ventas will acquire all of the outstanding shares of NHP in a stock-for-stock transaction valued at $7.4 billion, creating one of the largest publicly traded REITs and the leading healthcare REIT by equity value.
Amgen Inc. today announced results from three studies on the safety and efficacy of Nplate® (romiplostim) in adult patients with myelodysplastic syndromes (MDS).
› Verified 2 days ago
| Provider Name | Jeremy Kevin Wentz |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1649537192 PECOS PAC ID: 4587012935 Enrollment ID: I20231127001444 |
News Archive
The death of a 44-year-old man four days ago from bird flu has put Indonesia on a par with Vietnam when it comes to confirmed human deaths from the deadly virus.
Many clinical trials for breast cancer fail to give clear answers on the efficacy of new therapies, despite enrolling thousands of patients and painstakingly tracking their outcomes for years.
Researchers at The University of Texas Health Science Center at Houston (UTHealth) are launching a new research study to find the best way to give blood transfusions for severely injured patients predicted to require massive blood transfusions upon arrival to the Memorial Hermann-Texas Medical Center emergency department. Bryan Cotton, M.D., of UTHealth is principal investigator for this clinical study.
Ventas, Inc. and Nationwide Health Properties, Inc. today announced that the Boards of Directors of both companies have unanimously approved a definitive agreement under which Ventas will acquire all of the outstanding shares of NHP in a stock-for-stock transaction valued at $7.4 billion, creating one of the largest publicly traded REITs and the leading healthcare REIT by equity value.
Amgen Inc. today announced results from three studies on the safety and efficacy of Nplate® (romiplostim) in adult patients with myelodysplastic syndromes (MDS).
› Verified 2 days ago
| Provider Name | Aaron C Medina |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1154695955 PECOS PAC ID: 9436508439 Enrollment ID: I20231215003212 |
News Archive
The death of a 44-year-old man four days ago from bird flu has put Indonesia on a par with Vietnam when it comes to confirmed human deaths from the deadly virus.
Many clinical trials for breast cancer fail to give clear answers on the efficacy of new therapies, despite enrolling thousands of patients and painstakingly tracking their outcomes for years.
Researchers at The University of Texas Health Science Center at Houston (UTHealth) are launching a new research study to find the best way to give blood transfusions for severely injured patients predicted to require massive blood transfusions upon arrival to the Memorial Hermann-Texas Medical Center emergency department. Bryan Cotton, M.D., of UTHealth is principal investigator for this clinical study.
Ventas, Inc. and Nationwide Health Properties, Inc. today announced that the Boards of Directors of both companies have unanimously approved a definitive agreement under which Ventas will acquire all of the outstanding shares of NHP in a stock-for-stock transaction valued at $7.4 billion, creating one of the largest publicly traded REITs and the leading healthcare REIT by equity value.
Amgen Inc. today announced results from three studies on the safety and efficacy of Nplate® (romiplostim) in adult patients with myelodysplastic syndromes (MDS).
› Verified 2 days ago
| Provider Name | Sandra Kay Jones |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1891807343 PECOS PAC ID: 7618329277 Enrollment ID: I20240118003698 |
News Archive
The death of a 44-year-old man four days ago from bird flu has put Indonesia on a par with Vietnam when it comes to confirmed human deaths from the deadly virus.
Many clinical trials for breast cancer fail to give clear answers on the efficacy of new therapies, despite enrolling thousands of patients and painstakingly tracking their outcomes for years.
Researchers at The University of Texas Health Science Center at Houston (UTHealth) are launching a new research study to find the best way to give blood transfusions for severely injured patients predicted to require massive blood transfusions upon arrival to the Memorial Hermann-Texas Medical Center emergency department. Bryan Cotton, M.D., of UTHealth is principal investigator for this clinical study.
Ventas, Inc. and Nationwide Health Properties, Inc. today announced that the Boards of Directors of both companies have unanimously approved a definitive agreement under which Ventas will acquire all of the outstanding shares of NHP in a stock-for-stock transaction valued at $7.4 billion, creating one of the largest publicly traded REITs and the leading healthcare REIT by equity value.
Amgen Inc. today announced results from three studies on the safety and efficacy of Nplate® (romiplostim) in adult patients with myelodysplastic syndromes (MDS).
› Verified 2 days ago
| Provider Name | Cheryl B Cornwell |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1407958689 PECOS PAC ID: 2769825553 Enrollment ID: I20240208002460 |
News Archive
The death of a 44-year-old man four days ago from bird flu has put Indonesia on a par with Vietnam when it comes to confirmed human deaths from the deadly virus.
Many clinical trials for breast cancer fail to give clear answers on the efficacy of new therapies, despite enrolling thousands of patients and painstakingly tracking their outcomes for years.
Researchers at The University of Texas Health Science Center at Houston (UTHealth) are launching a new research study to find the best way to give blood transfusions for severely injured patients predicted to require massive blood transfusions upon arrival to the Memorial Hermann-Texas Medical Center emergency department. Bryan Cotton, M.D., of UTHealth is principal investigator for this clinical study.
Ventas, Inc. and Nationwide Health Properties, Inc. today announced that the Boards of Directors of both companies have unanimously approved a definitive agreement under which Ventas will acquire all of the outstanding shares of NHP in a stock-for-stock transaction valued at $7.4 billion, creating one of the largest publicly traded REITs and the leading healthcare REIT by equity value.
Amgen Inc. today announced results from three studies on the safety and efficacy of Nplate® (romiplostim) in adult patients with myelodysplastic syndromes (MDS).
› Verified 2 days ago
| Provider Name | Dustin Fisher |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1669254462 PECOS PAC ID: 3072956739 Enrollment ID: I20240209000414 |
News Archive
The death of a 44-year-old man four days ago from bird flu has put Indonesia on a par with Vietnam when it comes to confirmed human deaths from the deadly virus.
Many clinical trials for breast cancer fail to give clear answers on the efficacy of new therapies, despite enrolling thousands of patients and painstakingly tracking their outcomes for years.
Researchers at The University of Texas Health Science Center at Houston (UTHealth) are launching a new research study to find the best way to give blood transfusions for severely injured patients predicted to require massive blood transfusions upon arrival to the Memorial Hermann-Texas Medical Center emergency department. Bryan Cotton, M.D., of UTHealth is principal investigator for this clinical study.
Ventas, Inc. and Nationwide Health Properties, Inc. today announced that the Boards of Directors of both companies have unanimously approved a definitive agreement under which Ventas will acquire all of the outstanding shares of NHP in a stock-for-stock transaction valued at $7.4 billion, creating one of the largest publicly traded REITs and the leading healthcare REIT by equity value.
Amgen Inc. today announced results from three studies on the safety and efficacy of Nplate® (romiplostim) in adult patients with myelodysplastic syndromes (MDS).
› Verified 2 days ago
News Archive
The death of a 44-year-old man four days ago from bird flu has put Indonesia on a par with Vietnam when it comes to confirmed human deaths from the deadly virus.
Many clinical trials for breast cancer fail to give clear answers on the efficacy of new therapies, despite enrolling thousands of patients and painstakingly tracking their outcomes for years.
Researchers at The University of Texas Health Science Center at Houston (UTHealth) are launching a new research study to find the best way to give blood transfusions for severely injured patients predicted to require massive blood transfusions upon arrival to the Memorial Hermann-Texas Medical Center emergency department. Bryan Cotton, M.D., of UTHealth is principal investigator for this clinical study.
Ventas, Inc. and Nationwide Health Properties, Inc. today announced that the Boards of Directors of both companies have unanimously approved a definitive agreement under which Ventas will acquire all of the outstanding shares of NHP in a stock-for-stock transaction valued at $7.4 billion, creating one of the largest publicly traded REITs and the leading healthcare REIT by equity value.
Amgen Inc. today announced results from three studies on the safety and efficacy of Nplate® (romiplostim) in adult patients with myelodysplastic syndromes (MDS).
› Verified 2 days ago
United Summit Center Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6 Hospital Plz, Clarksburg, WV 26301 Phone: 304-623-5661 Fax: 304-623-2180 | |
Clarksburg Treatment Center, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 706 Oakmound Rd, Clarksburg, WV 26301 Phone: 304-622-7511 Fax: 304-622-6856 | |
Genesis Family Development Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 192 Safe Haven Dr, Clarksburg, WV 26301 Phone: 304-622-1907 Fax: 304-623-9346 | |
The Arc Of Harrison County Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 100 N 1st St, Clarksburg, WV 26301 Phone: 304-624-3641 Fax: 304-624-3802 | |
Family & Marital Counseling Center, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 321 W Main St, Suite 400, Clarksburg, WV 26301 Phone: 304-622-5323 Fax: 304-622-5324 | |
Deluca Family Wellness Center, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: Rt. 2 Box 406 Suite 121, Clarksburg, WV 26301 Phone: 304-626-3541 Fax: 304-626-3174 | |
Crimson Counseling Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 443 W Pike St, Clarksburg, WV 26301 Phone: 304-622-4786 Fax: 304-622-7210 |